Skip to main content
. 2024 Dec 12;8(12):e70075. doi: 10.1002/jgh3.70075

TABLE 1.

Patient characteristics in the study.

Characteristics Total (n = 88) CEMR (n = 42) UEMR (n = 46) p
Age, median, (min—max) 58 (27–85) 61 (27–83) 59 (35–85) 0.384**
Sex, n (%) 0.157
Male 54 (61.4) 29 (69.0) 25 (54.3)
Female 34 (38.6) 13 (31.0) 21 (45.7)
Indication for colonoscopy, n (%)
Abdominal pain 24 (27.3) 13 (31.0) 11 (23.9) 0.459
Screening 23 (26.1) 8 (19.0) 15 (32.6) 0.148
Blood in stool 5 (5.7) 2 (4.8) 3 (6.5) 1*
Diarrhea 9 (10.2) 3 (7.1) 6 (13.0) 0.489*
Constipation 17 (19.3) 9 (21.4) 8 (17.4) 0.632
Postoperation CRC 9 (10.2) 7 (16.7) 2 (4.3) 0.080*
Stool change 1 (1.1) 0 (0.0) 1 (2.2) 1*
Clinical symptoms, n (%)
No symptom 33 (37.5) 15 (35.7) 18 (39.1) 0.741
Abdominal pain 22 (25.0) 11 (26.2) 11 (23.9) 0.805
Diarrhea 11 (12.5) 6 (14.3) 5 (10.9) 0.628
Blood in stool 5 (5.7) 1 (2.4) 4 (8.7) 0.363*
Constipation 17 (19.3) 9 (21.4) 8 (17.4) 0.632
Hypertension, n (%) 45 (51.1) 20 (47.6) 25 (54.3) 0.528
Diabetes, n (%) 8 (9.1) 5 (11.9) 3 (6.5) 0.471*
Kidney failure, n (%) 2 (2.3) 0 (0.0) 2 (4.3) 0.495*
Personal history of CRC, n (%) 3 (3.4) 2 (4.8) 1 (2.2) 0.604*
Family history of CRC, n (%) 2 (2.3) 1 (2.4) 1 (2.2) 1*

Abbreviations: CEMR, conventional endoscopic mucosal resection; CRC, colorectal cancer; UEMR, underwater endoscopic mucosal resection.

*

Fisher's exact test.

**

Mann–Whitney U test.